Mobile Lads Corporation (MOBO)

[MRc2]

Relai Neuro CEO Appointed as Interim CEO to Avail Scientific


TORONTO, ON / ACCESSWIRE / January 26, 2023 / MOBILE LADS CORP, doing business as AVAIL SCIENTIFIC ("AVAIL") / (OTC PINK:MOBO) is pleased to announce Dr. James Thompson will be appointed as Interim CEO of Avail Scientific. This appointment follows Avail's January 10th, 2023 announcement of having signed a Letter of Intent that outlined the terms for the acquisition of Relai Neuro at which Dr. Thompson is currently CEO.

Dr. Thompson's professional experience in neurological testing and analytics, his work in founding, growing, and consulting with medical technology companies, and his passion for the mental health space will be instrumental in guiding Avail Scientific's pursuit of supporting psychedelic medicine research and treatments through neurological testing, data analytics, and data management.

Dr. Thompson states, "I am excited to help lead Avail Scientific. One of my first goals will be to build out our management team as well as to establish key strategic partnerships over the next few months in order to position us to achieve our collective mission."

Current CEO, Michael Paul will retain his role as President and Chairman of the Board of Directors of Avail. "We are excited to have Dr. Thompson take on the Interim CEO role at Avail as it aligns itself with Relai Neuro to become a much stronger single company. We are confident that Dr. Thompson can help drive the company toward its goal of becoming a world leader in the development of psychedelic therapeutics for the treatment of addiction & mental health issues," said Michael Paul.


https://finance.yahoo.com/news/relai-neuro-ceo-appointed-interim-150000986.html